[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Coronavirus Diagnostics Market, By Type of Test (Molecular v/s Serology), By User (Multiple v/s Single),

June 2021 | 112 pages | ID: G9B2031C090EEN
TechSci Research

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global coronavirus diagnostics market was valued at USD73538.02 million in 2020 and is expected to reach USD15579.56 million by 2026.The global coronavirus diagnostics market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

The ongoing coronavirus disease is caused due to SARS-COV-2 virus and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. First case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 20th May 2021, the total number of coronavirus cases crossed 165 million, globally, of which around 144 million had recovered and over 3 million people had died.

Europe and Asia-Pacific are expected to dominate the market during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions. Major players operating in the coronavirus diagnostics market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd., Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., PerkinElmer, Inc., Quest Diagnostics Inc., Hologic, Inc., Quidel Corporation, and others.

Years considered for this report:
  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022–2026
Objective of the Study:
  • To analyze the historical growth in the market size of the global coronavirus diagnostics market from 2016 to 2020.
  • To estimate and forecast the market size of the global coronavirus diagnostics market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global coronavirus diagnostics market based on type of test, user, full test time, end user, company and regional distribution.
  • To identify dominant regions and segments in the global coronavirus diagnostics market.
  • To identify drivers and challenges for global coronavirus diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus diagnostics market.
  • To identify and analyze the profile of leading players operating in global coronavirus diagnostics market.
  • To identify key sustainable strategies adopted by market players in global coronavirus diagnostics market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of diagnostic players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the market players which could not be identified due to the limitations of secondary research.

TechSci Research calculated the market size of global coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
  • Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to coronavirus diagnostics
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders, besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global coronavirus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
  • Global Coronavirus Diagnostics Market, By Type of Test:
    • Molecular
    • Serology
  • Global Coronavirus Diagnostics Market, By User:
    • Multiple
    • Single
  • Global Coronavirus Diagnostics Market, By Full Test Time:
    • 1 Hour - 12 Hours
    • Less Than 60 Minutes
    • 13 Hours - 24 Hours
    • More Than 1 Day
  • Global Coronavirus Diagnostics Market, By End User:
    • Hospitals
    • Public Health Labs
    • Private or Commercial Labs
    • Physician Labs
    • Others
  • Global Coronavirus Diagnostics Market, By Region:
    • Europe
      • United Kingdom
      • Russia
      • France
      • Italy
      • Germany
      • Spain
    • Asia-Pacific
      • India
      • China
      • Australia
      • Japan
      • Singapore
      • South Korea
      • Thailand
    • North America
      • United States
      • Canada
      • Mexico
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Iran
      • South Africa
      • Kuwait
    • South America
      • Brazil
      • Colombia
      • Argentina
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. IMPACT OF COVID-19 ON GLOBAL CORONAVIRUS DIAGNOSTICS MARKET

5. VOICE OF CUSTOMER

5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Pricing Analysis
5.5. Unmet Needs/Challenges

6. GLOBAL CORONAVIRUS DIAGNOSTICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value & Volume
6.2. Market Share & Forecast
  6.2.1. By Type of Test (Molecular v/s Serology)
  6.2.2. By User (Multiple v/s Single)
  6.2.3. By Full Test Time (1 Hours to 12 Hours, Less Than 60 Minutes, 13 Hours-24 Hours, More Than 1 Days)
  6.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
  6.2.5. By Company (2020)
  6.2.6. By Region
6.3. Product Market Map

7. EUROPE CORONAVIRUS DIAGNOSTICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value & Volume
7.2. Market Share & Forecast
  7.2.1. By Type of Test
  7.2.2. By User
  7.2.3. By Full Test Time
  7.2.4. By End User
  7.2.5. By Country
7.3. Europe: Country Analysis
  7.3.1. United Kingdom Coronavirus Diagnostics Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value & Volume
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Type of Test
      7.3.1.2.2. By User
      7.3.1.2.3. By Full Test Time
      7.3.1.2.4. By End User
  7.3.2. Russia Coronavirus Diagnostics Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value & Volume
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Type of Test
      7.3.2.2.2. By User
      7.3.2.2.3. By Full Test Time
      7.3.2.2.4. By End User
  7.3.3. France Coronavirus Diagnostics Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value & Volume
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Type of Test
      7.3.3.2.2. By User
      7.3.3.2.3. By Full Test Time
      7.3.3.2.4. By End User
  7.3.4. Italy Coronavirus Diagnostics Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value & Volume
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Type of Test
      7.3.4.2.2. By User
      7.3.4.2.3. By Full Test Time
      7.3.4.2.4. By End User
  7.3.5. Germany Coronavirus Diagnostics Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value & Volume
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Type of Test
      7.3.5.2.2. By User
      7.3.5.2.3. By Full Test Time
      7.3.5.2.4. By End User
  7.3.6. Spain Coronavirus Diagnostics Market Outlook
    7.3.6.1. Market Size & Forecast
      7.3.6.1.1. By Value & Volume
    7.3.6.2. Market Share & Forecast
      7.3.6.2.1. By Type of Test
      7.3.6.2.2. By User
      7.3.6.2.3. By Full Test Time
      7.3.6.2.4. By End User

8. ASIA-PACIFIC CORONAVIRUS DIAGNOSTICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value & Volume
8.2. Market Share & Forecast
  8.2.1. By Type of Test
  8.2.2. By User
  8.2.3. By End User
  8.2.4. By Full Test Time
  8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
  8.3.1. India Coronavirus Diagnostics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value & Volume
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Type of Test
      8.3.1.2.2. By User
      8.3.1.2.3. By Full Test Time
      8.3.1.2.4. By End User
  8.3.2. China Coronavirus Diagnostics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value & Volume
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Type of Test
      8.3.2.2.2. By User
      8.3.2.2.3. By Full Test Time
      8.3.2.2.4. By End User
  8.3.3. Australia Coronavirus Diagnostics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value & Volume
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Type of Test
      8.3.3.2.2. By User
      8.3.3.2.3. By Full Test Time
      8.3.3.2.4. By End User
  8.3.4. Japan Coronavirus Diagnostics Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value & Volume
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Type of Test
      8.3.4.2.2. By User
      8.3.4.2.3. By Full Test Time
      8.3.4.2.4. By End User
  8.3.5. Singapore Coronavirus Diagnostics Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value & Volume
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Type of Test
      8.3.5.2.2. By User
      8.3.5.2.3. By Full Test Time
      8.3.5.2.4. By End User
  8.3.6. South Korea Coronavirus Diagnostics Market Outlook
    8.3.6.1. Market Size & Forecast
      8.3.6.1.1. By Value & Volume
    8.3.6.2. Market Share & Forecast
      8.3.6.2.1. By Type of Test
      8.3.6.2.2. By User
      8.3.6.2.3. By Full Test Time
      8.3.6.2.4. By End User
  8.3.7. Thailand Coronavirus Diagnostics Market Outlook
    8.3.7.1. Market Size & Forecast
      8.3.7.1.1. By Value & Volume
    8.3.7.2. Market Share & Forecast
      8.3.7.2.1. By Type of Test
      8.3.7.2.2. By User
      8.3.7.2.3. By Full Test Time
      8.3.7.2.4. By End User

9. NORTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value & Volume
9.2. Market Share & Forecast
  9.2.1. By Type of Test
  9.2.2. By User
  9.2.3. By Full Test Time
  9.2.4. By End User
  9.2.5. By Country
9.3. North America: Country Analysis
  9.3.1. United States Coronavirus Diagnostics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value & Volume
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Type of Test
      9.3.1.2.2. By User
      9.3.1.2.3. By Full Test Time
      9.3.1.2.4. By End User
  9.3.2. Canada Coronavirus Diagnostics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value & Volume
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Type of Test
      9.3.2.2.2. By User
      9.3.2.2.3. By Full Test Time
      9.3.2.2.4. By End User
  9.3.3. Mexico Coronavirus Diagnostics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value & Volume
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Type of Test
      9.3.3.2.2. By User
      9.3.3.2.3. By Full Test Time
      9.3.3.2.4. By End User

10. MIDDLE EAST & AFRICA CORONAVIRUS DIAGNOSTICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value & Volume
10.2. Market Share & Forecast
  10.2.1. By Type of Test
  10.2.2. By User
  10.2.3. By Full Test Time
  10.2.4. By End User
  10.2.5. By Country
10.3. Middle East & Africa: Country Analysis
  10.3.1. UAE Coronavirus Diagnostics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value & Volume
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Type of Test
      10.3.1.2.2. By User
      10.3.1.2.3. By Full Test Time
      10.3.1.2.4. By End User
  10.3.2. Saudi Arabia Coronavirus Diagnostics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value & Volume
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Type of Test
      10.3.2.2.2. By User
      10.3.2.2.3. By Full Test Time
      10.3.2.2.4. By End User
  10.3.3. Iran Coronavirus Diagnostics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value & Volume
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Type of Test
      10.3.3.2.2. By User
      10.3.3.2.3. By Full Test Time
      10.3.3.2.4. By End User
  10.3.4. South Africa Coronavirus Diagnostics Market Outlook
    10.3.4.1. Market Size & Forecast
      10.3.4.1.1. By Value & Volume
    10.3.4.2. Market Share & Forecast
      10.3.4.2.1. By Type of Test
      10.3.4.2.2. By User
      10.3.4.2.3. By Full Test Time
      10.3.4.2.4. By End User
  10.3.5. Kuwait Coronavirus Diagnostics Market Outlook
    10.3.5.1. Market Size & Forecast
      10.3.5.1.1. By Value & Volume
    10.3.5.2. Market Share & Forecast
      10.3.5.2.1. By Type of Test
      10.3.5.2.2. By User
      10.3.5.2.3. By Full Test Time
      10.3.5.2.4. By End User

11. SOUTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value & Volume
11.2. Market Share & Forecast
  11.2.1. By Type of Test
  11.2.2. By User
  11.2.3. By Full Test Time
  11.2.4. By End User
  11.2.5. By Country
11.3. South America: Country Analysis
  11.3.1. Brazil Coronavirus Diagnostics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value & Volume
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Type of Test
      11.3.1.2.2. By User
      11.3.1.2.3. By Full Test Time
      11.3.1.2.4. By End User
  11.3.2. Colombia Coronavirus Diagnostics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value & Volume
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Type of Test
      11.3.2.2.2. By User
      11.3.2.2.3. By Full Test Time
      11.3.2.2.4. By End User
  11.3.3. Argentina Coronavirus Diagnostics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value & Volume
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Type of Test
      11.3.3.2.2. By User
      11.3.3.2.3. By Full Test Time
      11.3.3.2.4. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Abbott Laboratories
14.2. Altona Diagnostics GmbH
14.3. BioMerieux SA
14.4. Bio-Rad Laboratories, Inc.
14.5. Danaher Corporation
14.6. F.Hoffmann-La Roche Ltd
14.7. GSK Biologicals SA
14.8. Mylab Discovery Solutions Pvt. Ltd.
14.9. Seegene Inc.
14.10. Siemens AG
14.11. Thermo Fisher Scientific Inc.
14.12. PerkinElmer, Inc.
14.13. Quest Diagnostics Inc.
14.14. Hologic, Inc.
14.15. Quidel Corporation

15. STRATEGIC RECOMMENDATIONS

16. ABOUT US & DISCLAIMER

LIST OF FIGURES

Figure 1: Global Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 3: Global Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 4: Global Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 5: Global Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 6: Global Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 7: Global Coronavirus Diagnostics Market, Product Market Map, By Company, By Value (USD Million), 2016-2026F
Figure 8: Global Coronavirus Diagnostics Market, Product Market Map, By Region, By Value (USD Million), 2016-2026F
Figure 9: Europe Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 10: Europe Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 11: Europe Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 12: Europe Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 13: Europe Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 14: Europe Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 15: Europe Coronavirus Diagnostics Market, By Country, 2016-2026F
Figure 16: United Kingdom Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 17: United Kingdom Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 18: United Kingdom Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 19: United Kingdom Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 20: United Kingdom Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 21: United Kingdom Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 22: Russia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 23: Russia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 24: Russia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 25: Russia Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 26: Russia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 27: Russia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 28: France Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 29: France Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 30: France Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 31: France Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 32: France Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 33: France Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 34: Italy Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 35: Italy Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 36: Italy Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 37: Italy Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 38: Italy Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 39: Italy Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 40: Germany Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 41: Germany Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 42: Germany Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 43: Germany Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 44: Germany Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 45: Germany Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 46: Spain Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 47: Spain Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 48: Spain Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 49: Spain Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 50: Spain Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 51: Spain Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 52: Asia-Pacific Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 53: Asia-Pacific Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 54: Asia-Pacific Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 55: Asia-Pacific Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 56: Asia-Pacific Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 57: Asia-Pacific Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 58: Asia-Pacific Coronavirus Diagnostics Market, By Country, 2016-2026F
Figure 59: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 60: India Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 61: India Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 62: India Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 63: India Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 64: India Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 65: China Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 66: China Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 67: China Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 68: China Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 69: China Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 70: China Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 71: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 72: Australia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 73: Australia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 74: Australia Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 75: Australia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 76: Australia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 77: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 78: Japan Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 79: Japan Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 80: Japan Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 81: Japan Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 82: Japan Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 83: Singapore Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 84: Singapore Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 85: Singapore Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 86: Singapore Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 87: Singapore Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 88: Singapore Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 89: South Korea Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 90: South Korea Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 91: South Korea Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 92: South Korea Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 93: South Korea Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 94: South Korea Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 95: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 96: Thailand Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 97: Thailand Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 98: Thailand Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 99: Thailand Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 100: Thailand Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 101: North America Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 102: North America Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 103: North America Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 104: North America Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 105: North America Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 106: North America Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 107: North America Coronavirus Diagnostics Market, By Country, 2016-2026F
Figure 108: United States Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 109: United States Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 110: United States Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 111: United States Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 112: United States Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 113: United States Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 114: Canada Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 115: Canada Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 116: Canada Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 117: Canada Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 118: Canada Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 119: Canada Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 120: Mexico Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 121: Mexico Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 122: Mexico Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 123: Mexico Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 124: Mexico Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 125: Mexico Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 126: Middle East & Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 127: Middle East & Africa Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 128: Middle East & Africa Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 129: Middle East & Africa Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 130: Middle East & Africa Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 131: Middle East & Africa Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 132: Middle East & Africa Coronavirus Diagnostics Market, By Country, 2016-2026F
Figure 133: UAE Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 134: UAE Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 135: UAE Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 136: UAE Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 137: UAE Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 138: UAE Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 139: Saudi Arabia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 140: Saudi Arabia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 141: Saudi Arabia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 142: Saudi Arabia Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 143: Saudi Arabia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 144: Saudi Arabia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 145: Iran Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 146: Iran Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 147: Iran Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 148: Iran Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 149: Iran Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 150: Iran Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 151: South Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 152: South Africa Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 153: South Africa Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 154: South Africa Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 155: South Africa Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 156: South Africa Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 157: Kuwait Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 158: Kuwait Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 159: Kuwait Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 160: Kuwait Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 161: Kuwait Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 162: Kuwait Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 163: South America Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 164: South America Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 165: South America Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 166: South America Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 167: South America Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 168: South America Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 169: South America Coronavirus Diagnostics Market, By Country, 2016-2026F
Figure 170: Brazil Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 171: Brazil Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 172: Brazil Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 173: Brazil Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 174: Brazil Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 175: Brazil Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 176: Colombia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 177: Colombia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 178: Colombia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 179: Colombia Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 180: Colombia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 181: Colombia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
Figure 182: Argentina Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
Figure 183: Argentina Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
Figure 184: Argentina Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
Figure 185: Argentina Coronavirus Diagnostics Market Share, By User, 2016-2026F
Figure 186: Argentina Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
Figure 187: Argentina Coronavirus Diagnostics Market Share, By End User, 2016-2026F

More Publications

Need Help?

Ask a Question

Market Reports

All Categories